AMUNNI, GIANNI

AMUNNI, GIANNI  

Scienze Biomediche, Sperimentali e Cliniche 'Mario Serio'  

Mostra records
Risultati 1 - 20 di 42 (tempo di esecuzione: 0.079 secondi).
Titolo Data di pubblicazione Autore(i) File
[Bcl-2 in ovarian carcinoma: a clinicopathologic, immunohistochemical and molecular study]. 2004 Raspollini MR;Castiglione F;Rossi Degl'Innocenti D;Baroni G;Amunni G;Villanucci A;Taddei GL
Aspetti psicosociali dell’adattamento alla malattia in pazienti oncologiche 2006 G. Amunni; C. Stefanile; P. Meringolo; E. Serafini
Assessing psychological needs in female cancer patients: A tailored model 2021 Miraglia Raineri A.; Lauro Grotto R.; Fioravanti G.; Casale S.; Rotella F.; Fei L.; Villanucci A.; Amunni G.; Faravelli C.
C-KIT EXPRESSION AND CORRELATION WITH CHEMOTERAPY RESISTANCE IN OVARIAN CARCINOMA: AN IMMUNOCYTOCHEMICAL STUDY 2004 M. RASPOLLINI; G. AMUNNI; A. VILLANUCCI; G. BARONI; A. TADDEI; G. TADDEI
C-kit expression in uterine leiomyosarcomas: an immunocytochemical study of 29 cases of malignant smooth muscle tumors of the uterus. 2003 Raspollini M.R.; Villanucci A.; Amunni G.; Paglierani M.; Taddei A.; Taddei G.L.
Correlation of in vitro drug sensitivity and clinical response in ovarian carcinoma using an ATP-luminescence tumor chemosensitivity assay 1999 E. Mini; P. Pinzani; G. Amunni; A. Villanucci; T. Mazzei; M. Pazzagli
COX-2 and preoperative CA-125 level are strongly correlated with survival and clinical responsiveness to chemiotherapy in ovarian cancer. 2006 M.R. RASPOLLINI; G. AMUNNI; A. VILLANUCCI; V. BODDI; G.L. TADDEI;
COX-2 status in relation to tumor microvessel density and VEGF expression: analysis in ovarian carcinoma patients with low versus high survival rates. 2004 M.R. RASPOLLINI; G. AMUNNI; A. VILLANUCCI; V. BODDI; G. MARONI; A. TADDEI; G.L. TADDEI;
COX-2, c-KIT and HER-2/neu expression in uterine carcinosarcomas: prognostic factors or potential markers for targeted therapies? 2005 RASPOLLINI MR; SUSINI T; AMUNNI G; PAGLIERANI M; TADDEI A; MARCHIONNI M; G. SCARSELLI; TADDEI GL.
Cyclooxygenase-2 expression in uterine leiomyosarcomas. 2004 Raspollini M.R.; Amunni G.; Villanucci A.; Paglierani M.; Taddei G.L.
Cyclooxygenase-2, angiogenesis, tumor cell proliferation, P-glycoprotein in advanced ovarian serous carcinoma 2006 Maria Rosaria Raspollini;Gianni Amunni;Alessandro Villanucci;Gianna Baroni;Gian Luigi Taddei
DNA ploidy is stronger than lymph node metastasis as prognostic factor in cervical carcinoma: 10-year results of a prospective study 2011 Susini T; Olivieri S; Molino C; Amunni G; Rapi S; Taddei G; Scarselli G.
Druggable targets meet oncogenic drivers: opportunities and limitations of target-based classification of tumors and the role of Molecular Tumor Boards 2021 Danesi, R; Fogli, S; Indraccolo, S; Del Re, M; Dei Tos, A P; Leoncini, L; Antonuzzo, L; Bonanno, L; Guarneri, V; Pierini, A; Amunni, G; Conte, P
Early life events and gynaecological cancer: a pilot study 2012 Carlo Faravelli; Giulia Fioravanti; Silvia Casale; Davide Paciello; Alessandra Miraglia Raineri; Leonardo Fei; Gianni Amunni; Francesco Rotella
EPITHELIAL OVARIAN TUMORS IN THE REPRODUCTIVE AGE GROUP: AGE IS NOT AN INDEPENDENT PROGNOSTIC FACTOR 1996 D. MASSI; T. SUSINI; L. SAVINO; V. BODDI; G. AMUNNI; M. COLAFRANCESCHI.
Estrogen and progesterone receptors expression in uterine malignant smooth muscletumors: correlation with clinical outcome. 2003 Raspollini M.R.; Amunni G.; Villanucci A.; Boddi V.; Simoni A.; Taddei A.; Taddei G.L.
Expression and amplification of HER-2/neu oncogene in uterine carcinosarcomas: a marker for potential molecularly targeted treatment? 2006 Raspollini M.R.; Susini T.; Amunni G.; Paglierani M.; Castiglione F.; Garbini F.; Carriero C.; Scarselli G.; Taddei G.L.
EXPRESSION OF INDUCILE NITRIC OXIDE SYNTHASE AND CYCLOOXYGENASE-2 IN OVARIAN CANCER: CORRRELATION WITH CLINICAL OUTCOME 2004 M. RASPOLLINI; G. AMUNNI; A. VILLANUCCI; V. BODDI; G. BARONI; A. TADDEI; G. TADDEI
Frequent loss of expression of the cyclin-dependent kinase inhibitor p27(Kip1) in estrogen-related Endometrial adenocarcinomas. 2003 V. MASCIULLO; T. SUSINI; A. ZAMPARELLI; A. BOVICELLI; C. MINIMO; D. MASSI; GL. TADDEI; N. MAGGIANO; P. DE IACO; M. CECCARONI; L. BOVICELLI; G. AMUNNI; S. MANCUSO; G. SCAMBIA ; A. GIORDANO.
HER-2/neu and bcl-2 in ovarian carcinoma: clinicopathologic, immunohistochemical, and molecular study in patients with shorter and longer survival. 2006 M. R. Raspollini;G. Amunni;A. Villanucci;F. Castiglione;D. R. Degl'Innocenti;G. Baroni;M. Paglierani;G. L. Taddei